GENEDX HOLDINGS CORP (WGS) Stock Fundamental Analysis
USA - NASDAQ:WGS - US81663L2007 - Common Stock
139.73 USD
+1.03 (+0.74%)
139.632 USD
-0.1 (-0.07%)
Overall WGS gets a fundamental rating of 5 out of 10. We evaluated WGS against 100 industry peers in the Health Care Providers & Services industry. While WGS has a great health rating, there are worries on its profitability. WGS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
WGS had positive earnings in the past year.
In the past year WGS had a positive cash flow from operations.
In the past 5 years WGS always reported negative net income.
WGS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.42%, WGS perfoms like the industry average, outperforming 49.00% of the companies in the same industry.
With a Return On Equity value of 0.71%, WGS perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
With a Return On Invested Capital value of 1.94%, WGS perfoms like the industry average, outperforming 43.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| ROIC | 1.94% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WGS's Profit Margin of 0.52% is in line compared to the rest of the industry. WGS outperforms 49.00% of its industry peers.
WGS's Operating Margin of 2.48% is in line compared to the rest of the industry. WGS outperforms 50.00% of its industry peers.
WGS's Gross Margin of 69.65% is amongst the best of the industry. WGS outperforms 86.00% of its industry peers.
WGS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.48% | ||
| PM (TTM) | 0.52% | ||
| GM | 69.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WGS is destroying value.
Compared to 1 year ago, WGS has more shares outstanding
WGS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, WGS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 9.26 indicates that WGS is not in any danger for bankruptcy at the moment.
WGS has a Altman-Z score of 9.26. This is amongst the best in the industry. WGS outperforms 94.00% of its industry peers.
The Debt to FCF ratio of WGS is 3.41, which is a good value as it means it would take WGS, 3.41 years of fcf income to pay off all of its debts.
WGS has a better Debt to FCF ratio (3.41) than 74.00% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that WGS is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.18, WGS is doing good in the industry, outperforming 71.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 3.41 | ||
| Altman-Z | 9.26 |
ROIC/WACC0.21
WACC9.14%
2.3 Liquidity
WGS has a Current Ratio of 2.71. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of WGS (2.71) is better than 84.00% of its industry peers.
A Quick Ratio of 2.59 indicates that WGS has no problem at all paying its short term obligations.
WGS has a Quick ratio of 2.59. This is amongst the best in the industry. WGS outperforms 83.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.71 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 274.07%, which is quite impressive.
WGS shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.50%.
WGS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.26% yearly.
EPS 1Y (TTM)274.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1125%
Revenue 1Y (TTM)50.5%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%51.86%
3.2 Future
The Earnings Per Share is expected to grow by 80.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, WGS will show a very strong growth in Revenue. The Revenue will grow by 26.73% on average per year.
EPS Next Y644.01%
EPS Next 2Y177.61%
EPS Next 3Y132.41%
EPS Next 5Y80.72%
Revenue Next Year45.41%
Revenue Next 2Y33.46%
Revenue Next 3Y28.87%
Revenue Next 5Y26.73%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
WGS is valuated quite expensively with a Price/Earnings ratio of 74.32.
Compared to the rest of the industry, the Price/Earnings ratio of WGS is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 25.83. WGS is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 78.83, which means the current valuation is very expensive for WGS.
WGS's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, WGS is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 74.32 | ||
| Fwd PE | 78.83 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, WGS is valued a bit more expensive than the industry average as 64.00% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WGS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 259.57 | ||
| EV/EBITDA | 112.9 |
4.3 Compensation for Growth
WGS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WGS's earnings are expected to grow with 132.41% in the coming years.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y177.61%
EPS Next 3Y132.41%
5. Dividend
5.1 Amount
No dividends for WGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
139.73
+1.03 (+0.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners110.59%
Inst Owner Change0.7%
Ins Owners1.55%
Ins Owner Change0.63%
Market Cap4.01B
Revenue(TTM)402.19M
Net Income(TTM)2.08M
Analysts83.08
Price Target132.26 (-5.35%)
Short Float %11.92%
Short Ratio5.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)200.04%
Min EPS beat(2)14.73%
Max EPS beat(2)385.34%
EPS beat(4)4
Avg EPS beat(4)260.69%
Min EPS beat(4)14.73%
Max EPS beat(4)385.34%
EPS beat(8)8
Avg EPS beat(8)161.06%
EPS beat(12)9
Avg EPS beat(12)102.92%
EPS beat(16)12
Avg EPS beat(16)78.7%
Revenue beat(2)2
Avg Revenue beat(2)14.71%
Min Revenue beat(2)10.43%
Max Revenue beat(2)18.99%
Revenue beat(4)4
Avg Revenue beat(4)12.86%
Min Revenue beat(4)6.85%
Max Revenue beat(4)18.99%
Revenue beat(8)8
Avg Revenue beat(8)13.89%
Revenue beat(12)11
Avg Revenue beat(12)9.25%
Revenue beat(16)14
Avg Revenue beat(16)5.95%
PT rev (1m)4.78%
PT rev (3m)24%
EPS NQ rev (1m)2.31%
EPS NQ rev (3m)26.6%
EPS NY rev (1m)0%
EPS NY rev (3m)71.05%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)3.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 74.32 | ||
| Fwd PE | 78.83 | ||
| P/S | 9.98 | ||
| P/FCF | 259.57 | ||
| P/OCF | 120.97 | ||
| P/B | 13.74 | ||
| P/tB | 37.56 | ||
| EV/EBITDA | 112.9 |
EPS(TTM)1.88
EY1.35%
EPS(NY)1.77
Fwd EY1.27%
FCF(TTM)0.54
FCFY0.39%
OCF(TTM)1.16
OCFY0.83%
SpS14
BVpS10.17
TBVpS3.72
PEG (NY)0.12
PEG (5Y)N/A
Graham Number20.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| ROCE | 2.45% | ||
| ROIC | 1.94% | ||
| ROICexc | 3.13% | ||
| ROICexgc | 11.96% | ||
| OM | 2.48% | ||
| PM (TTM) | 0.52% | ||
| GM | 69.65% | ||
| FCFM | 3.85% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score8
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 3.41 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 74.14% | ||
| Cap/Sales | 4.41% | ||
| Interest Coverage | 1.83 | ||
| Cash Conversion | 98% | ||
| Profit Quality | 742.49% | ||
| Current Ratio | 2.71 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 9.26 |
F-Score8
WACC9.14%
ROIC/WACC0.21
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)274.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1125%
EPS Next Y644.01%
EPS Next 2Y177.61%
EPS Next 3Y132.41%
EPS Next 5Y80.72%
Revenue 1Y (TTM)50.5%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%51.86%
Revenue Next Year45.41%
Revenue Next 2Y33.46%
Revenue Next 3Y28.87%
Revenue Next 5Y26.73%
EBIT growth 1Y117.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year681.51%
EBIT Next 3Y147.48%
EBIT Next 5YN/A
FCF growth 1Y106.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.44%
OCF growth 3YN/A
OCF growth 5YN/A
GENEDX HOLDINGS CORP / WGS FAQ
Can you provide the ChartMill fundamental rating for GENEDX HOLDINGS CORP?
ChartMill assigns a fundamental rating of 5 / 10 to WGS.
What is the valuation status of GENEDX HOLDINGS CORP (WGS) stock?
ChartMill assigns a valuation rating of 3 / 10 to GENEDX HOLDINGS CORP (WGS). This can be considered as Overvalued.
What is the profitability of WGS stock?
GENEDX HOLDINGS CORP (WGS) has a profitability rating of 3 / 10.
What is the financial health of GENEDX HOLDINGS CORP (WGS) stock?
The financial health rating of GENEDX HOLDINGS CORP (WGS) is 7 / 10.
What is the expected EPS growth for GENEDX HOLDINGS CORP (WGS) stock?
The Earnings per Share (EPS) of GENEDX HOLDINGS CORP (WGS) is expected to grow by 644.01% in the next year.